Viropil
Dolutegravir · Lamivudine · Tenofovir disoproxil
Viropil is a hiv medication containing Dolutegravir + Lamivudine + Tenofovir disoproxil, available as 50/300/300mg tablets.
- Category
- Hiv
- Active ingredient
- Dolutegravir · Lamivudine · Tenofovir disoproxil
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 50/300/300mg
Prescription rules on Viropil vary by country.
Details
- Conditions
- Hiv infection
- Therapeutic Class
- Antiretroviral
- Pharmacological Class
- Integrase Inhibitor, NRTI
- Minor Side Effects
- insomnia, nausea, fatigue, headache
- Moderate Side Effects
- dizziness, abnormal dreams, flatulence
- Dosage Forms
- Film-coated tablet
- Administration Route
- Oral use
- Prescription Status
- Prescription medicine
- Onset Time
- 1–2 weeks
- Duration
- Indefinite
- Storage Instructions
- Store in original container below 30°C.
- Drug Interactions
- metformin, antacids, calcium supplements
- Age Restrictions
- Adults and adolescents based on weight.